• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较缺血性与非缺血性心肌病患者导管消融治疗室性心律失常结局的荟萃分析。

Meta-analysis comparing outcomes of catheter ablation for ventricular arrhythmia in ischemic versus nonischemic cardiomyopathy.

机构信息

Department of Cardiology, Memphis VA Medical Center, 1030 Jefferson Ave, Memphis, TN, 38104.

School of Public Health, The University of Memphis, Memphis, TN, USA.

出版信息

Pacing Clin Electrophysiol. 2021 Jan;44(1):54-62. doi: 10.1111/pace.14129. Epub 2020 Nov 30.

DOI:10.1111/pace.14129
PMID:33216394
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7984079/
Abstract

BACKGROUND

Catheter ablation is an effective treatment for ventricular arrhythmia (VA) in ischemic cardiomyopathy (ICM). However, results in non-ICM (NICM) patients are not satisfactory, and studies comparing differences between NICM and ICM are limited. We conducted a meta-analysis of procedural characteristics and long-term outcomes of catheter ablation for VA, comparing results between ICM and NICM.

METHODS

Studies in the PubMed, EMBASE, and Cochrane databases were systematically reviewed. Four studies reporting comparison of catheter ablation of VA between ICM and NICM were examined. The Newcastle-Ottawa Scale was used to appraise study quality. A random-effects model with inverse variance method was used for comparisons.

RESULTS

Epicardial approach was significantly more undertaken for the NICM group than in the ICM group (odds ratio [OR]: 0.13; 95% confidence interval [CI]: 0.09-0.18; P < .00001). Mean ablation time (P = .54), fluoroscopy time (P = .55), and procedural time (P = .18) did not differ significantly between the ICM and NICM groups. Procedural failure rates (OR: 0.46; 95% CI: 0.24-0.89; P = .02) and VA recurrence rates (risk ratio [RR]: 0.68; 95% CI: 0.46-1.01; P = .06) were significantly higher in the NICM group than in the ICM group. However, all-cause mortality (RR: 1.37; 95% CI: 0.75-2.49; P = .31) did not differ significantly between groups.

CONCLUSIONS

Procedural failure and VA recurrence rates were significantly higher in the NICM group, despite significantly more frequent epicardial access. These highlight the limitations of catheter ablation for VA in NICM, given our current knowledge.

摘要

背景

导管消融是缺血性心肌病(ICM)患者室性心律失常(VA)的有效治疗方法。然而,非缺血性心肌病(NICM)患者的结果并不令人满意,并且比较 NICM 和 ICM 之间差异的研究有限。我们对导管消融治疗 VA 的程序特征和长期结果进行了荟萃分析,比较了 ICM 和 NICM 之间的结果。

方法

系统地回顾了 PubMed、EMBASE 和 Cochrane 数据库中的研究。检查了四项报告比较 ICM 和 NICM 之间 VA 导管消融的研究。使用纽卡斯尔-渥太华量表评估研究质量。采用具有逆方差法的随机效应模型进行比较。

结果

心外膜入路在 NICM 组中明显多于 ICM 组(比值比 [OR]:0.13;95%置信区间 [CI]:0.09-0.18;P<0.00001)。两组间平均消融时间(P=0.54)、透视时间(P=0.55)和手术时间(P=0.18)无显著差异。程序失败率(OR:0.46;95%CI:0.24-0.89;P=0.02)和 VA 复发率(风险比 [RR]:0.68;95%CI:0.46-1.01;P=0.06)在 NICM 组明显高于 ICM 组。然而,两组间全因死亡率(RR:1.37;95%CI:0.75-2.49;P=0.31)无显著差异。

结论

尽管心外膜入路更为频繁,但 NICM 组的程序失败率和 VA 复发率明显更高。鉴于我们目前的知识,这凸显了导管消融治疗 NICM 患者 VA 的局限性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc8e/7984079/7e893a931593/PACE-44-54-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc8e/7984079/9071783b1e7c/PACE-44-54-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc8e/7984079/7e893a931593/PACE-44-54-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc8e/7984079/9071783b1e7c/PACE-44-54-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc8e/7984079/7e893a931593/PACE-44-54-g002.jpg

相似文献

1
Meta-analysis comparing outcomes of catheter ablation for ventricular arrhythmia in ischemic versus nonischemic cardiomyopathy.比较缺血性与非缺血性心肌病患者导管消融治疗室性心律失常结局的荟萃分析。
Pacing Clin Electrophysiol. 2021 Jan;44(1):54-62. doi: 10.1111/pace.14129. Epub 2020 Nov 30.
2
Catheter Ablation for Ventricular Tachycardia in Ischaemic Versus Non-Ischaemic Cardiomyopathy: A Systematic Review and Meta-Analysis.导管消融治疗缺血性与非缺血性心肌病所致室性心动过速:系统评价和荟萃分析。
Heart Lung Circ. 2022 Aug;31(8):1064-1074. doi: 10.1016/j.hlc.2022.02.014. Epub 2022 May 25.
3
Characterization of the arrhythmogenic substrate in ischemic and nonischemic cardiomyopathy implications for catheter ablation of hemodynamically unstable ventricular tachycardia.探讨缺血性和非缺血性心肌病致心律失常基质的特征及其对血液动力学不稳定型室性心动过速导管消融的影响。
J Am Coll Cardiol. 2010 May 25;55(21):2355-65. doi: 10.1016/j.jacc.2010.01.041.
4
Comparison of the arrhythmogenic substrate for ventricular tachycardia in patients with ischemic vs non-ischemic cardiomyopathy - insights from high-density, multi-electrode catheter mapping.比较缺血性与非缺血性心肌病患者室性心动过速的致心律失常基质 - 来自高密度、多电极导管标测的见解。
J Interv Card Electrophysiol. 2023 Jan;66(1):5-14. doi: 10.1007/s10840-021-01088-7. Epub 2021 Nov 17.
5
Beyond the Storm: Comparison of Clinical Factors, Arrhythmogenic Substrate, and Catheter Ablation Outcomes in Structural Heart Disease Patients With versus Those Without a History of Ventricular Tachycardia Storm.风暴之外:有与无室性心动过速风暴病史的结构性心脏病患者临床因素、致心律失常基质及导管消融结果的比较
J Cardiovasc Electrophysiol. 2017 Jan;28(1):56-67. doi: 10.1111/jce.13117. Epub 2016 Nov 29.
6
Endocardial substrate mapping for monomorphic ventricular tachycardia ablation in ischemic and non-ischemic cardiomyopathy.缺血性和非缺血性心肌病中单形性室性心动过速消融的心内膜基质标测
Kobe J Med Sci. 2008 Jul 18;54(2):E122-35.
7
Long-term outcomes after catheter ablation of ventricular tachycardia in patients with and without structural heart disease.有结构性心脏病和无结构性心脏病患者行室性心动过速导管消融术后的长期预后
Heart Rhythm. 2016 Oct;13(10):1957-63. doi: 10.1016/j.hrthm.2016.07.001. Epub 2016 Jul 5.
8
Complication rates following ventricular tachycardia ablation in ischaemic and non-ischaemic cardiomyopathies: a systematic review.缺血性和非缺血性心肌病患者行室性心动过速消融术后的并发症发生率:系统评价。
J Interv Card Electrophysiol. 2022 Jan;63(1):59-67. doi: 10.1007/s10840-021-00948-6. Epub 2021 Jan 29.
9
Epicardial ablation of ventricular tachycardia: an institutional experience of safety and efficacy.心外膜消融治疗室性心动过速:安全性和疗效的机构经验。
Heart Rhythm. 2013 Apr;10(4):490-8. doi: 10.1016/j.hrthm.2012.12.013. Epub 2012 Dec 11.
10
Combined Endocardial-Epicardial Versus Endocardial Catheter Ablation Alone for Ventricular Tachycardia in Structural Heart Disease: A Systematic Review and Meta-Analysis.结构性心脏病室性心动过速心内膜与心外膜联合导管消融与单纯心内膜导管消融的比较:系统评价和荟萃分析。
JACC Clin Electrophysiol. 2019 Jan;5(1):13-24. doi: 10.1016/j.jacep.2018.08.010. Epub 2018 Sep 26.

引用本文的文献

1
Pre-ablation and Post-ablation Factors Influencing the Prognosis of Patients with Electrical Storm Treated by Radiofrequency Catheter Ablation: An Update.影响射频导管消融治疗电风暴患者预后的消融前及消融后因素:最新进展
Rev Cardiovasc Med. 2024 Dec 5;25(12):432. doi: 10.31083/j.rcm2512432. eCollection 2024 Dec.
2
Catheter ablation versus antiarrhythmic drug therapy for sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy.肥厚型心肌病伴持续性室性心动过速患者的导管消融与抗心律失常药物治疗比较。
BMC Cardiovasc Disord. 2024 May 16;24(1):255. doi: 10.1186/s12872-024-03924-w.
3
Sex differences on outcomes of catheter ablation of ventricular tachycardia in patients with structural heart disease: A real-world systematic review and meta-analysis.

本文引用的文献

1
Combined Endocardial-Epicardial Versus Endocardial Catheter Ablation Alone for Ventricular Tachycardia in Structural Heart Disease: A Systematic Review and Meta-Analysis.结构性心脏病室性心动过速心内膜与心外膜联合导管消融与单纯心内膜导管消融的比较:系统评价和荟萃分析。
JACC Clin Electrophysiol. 2019 Jan;5(1):13-24. doi: 10.1016/j.jacep.2018.08.010. Epub 2018 Sep 26.
2
Outcomes of Catheter Ablation of Ventricular Tachycardia Based on Etiology in Nonischemic Heart Disease: An International Ventricular Tachycardia Ablation Center Collaborative Study.非缺血性心脏病患者根据病因进行导管消融治疗室性心动过速的结果:一项国际室性心动过速消融中心协作研究。
JACC Clin Electrophysiol. 2018 Sep;4(9):1141-1150. doi: 10.1016/j.jacep.2018.05.007. Epub 2018 Jul 25.
3
结构性心脏病患者室性心动过速导管消融结局的性别差异:一项真实世界的系统评价和荟萃分析。
Heart Rhythm O2. 2022 Dec 16;3(6Part B):847-856. doi: 10.1016/j.hroo.2022.09.009. eCollection 2022 Dec.
4
Outcomes of early catheter ablation for ventricular tachycardia in adult patients with structural heart disease and implantable cardioverter-defibrillator: An updated systematic review and meta-analysis of randomized trials.患有结构性心脏病和植入式心律转复除颤器的成年患者早期导管消融治疗室性心动过速的结果:随机试验的最新系统评价和荟萃分析
Front Cardiovasc Med. 2022 Nov 30;9:1063147. doi: 10.3389/fcvm.2022.1063147. eCollection 2022.
Catheter ablation of ventricular tachycardia in nonischemic cardiomyopathy.非缺血性心肌病室性心动过速的导管消融术
J Arrhythm. 2018 Aug 28;34(4):347-355. doi: 10.1002/joa3.12099. eCollection 2018 Aug.
4
Cost Effectiveness of Ventricular Tachycardia Ablation Versus Escalation of Antiarrhythmic Drug Therapy: The VANISH Trial.室性心动过速消融与抗心律失常药物治疗升级的成本效果比较:VANISH 试验。
JACC Clin Electrophysiol. 2018 May;4(5):660-668. doi: 10.1016/j.jacep.2018.01.007. Epub 2018 Mar 28.
5
Long-Term Outcomes of Catheter Ablation of Electrical Storm in Nonischemic Dilated Cardiomyopathy Compared With Ischemic Cardiomyopathy.非缺血性扩张型心肌病与缺血性心肌病患者电风暴导管消融的长期预后比较。
JACC Clin Electrophysiol. 2017 Jul;3(7):767-778. doi: 10.1016/j.jacep.2017.01.020. Epub 2017 Apr 26.
6
Prophylactic catheter ablation of ventricular tachycardia in ischemic cardiomyopathy: a systematic review and meta-analysis of randomized controlled trials.缺血性心肌病中心室性心动过速的预防性导管消融:一项随机对照试验的系统评价和荟萃分析
J Interv Card Electrophysiol. 2018 Nov;53(2):207-215. doi: 10.1007/s10840-018-0376-5. Epub 2018 Apr 21.
7
Ablation Outcomes and Predictors of Mortality Following Catheter Ablation for Ventricular Tachycardia: Data From the German Multicenter Ablation Registry.导管消融治疗室性心动过速的消融结果和死亡率的预测因素:来自德国多中心消融登记处的数据。
J Am Heart Assoc. 2018 Mar 23;7(6):e007045. doi: 10.1161/JAHA.117.007045.
8
A meta-analysis of manual versus remote magnetic navigation for ventricular tachycardia ablation.一项关于心室性心动过速消融的手动与远程磁导航的荟萃分析。
J Interv Card Electrophysiol. 2017 Sep;49(3):227-235. doi: 10.1007/s10840-017-0257-3. Epub 2017 Jun 17.
9
Catheter Ablation for Ventricular Tachycardia in Patients with Nonischemic Cardiomyopathy.非缺血性心肌病患者室性心动过速的导管消融治疗
Card Electrophysiol Clin. 2017 Mar;9(1):47-54. doi: 10.1016/j.ccep.2016.10.003. Epub 2016 Dec 24.
10
Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure.非缺血性收缩性心力衰竭患者的除颤器植入
N Engl J Med. 2016 Sep 29;375(13):1221-30. doi: 10.1056/NEJMoa1608029. Epub 2016 Aug 27.